Summit Research Initiates Imperva At Buy
July 06, 2015 at 09:37 AM EDT
Summit Research initiated coverage on Imperva Inc (NYSE: IMPV) with a Buy rating. The target price for Imperva is set to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.